Chewapruek N. Incidence and risk factors of Trimethoprim/Sulfamethoxazole associated hyperkalemia in Pneumocystis jirovecii Pneumonia patients. JMPH4 [internet]. 2023 Apr. 4 [cited 2026 Sep. 1];13(1):71-83. available from: https://he01.tci-thaijo.org/index.php/JMPH4/article/view/259451